Performance characteristics of glycated albumin and its clinical usefulness in diabetic patients on hemodialysis

Korean Journal of Laboratory Medicine

Volumn 29, Issue 5, 2009, Pages 406-414

  Park, Hae il ^a   Kim, Yeong Sic ^a   Lee, Jehoon ^a   Kim, Yonggoo ^a   Shin, Seok Joon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Diabetes mellitus; Glucose; Glycated albumin; HbA1c; Hemodialysis

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

AGED; ANALYTICAL EQUIPMENT; ARTICLE; CHEMISTRY; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN;

EID: 77949324976     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2009.29.5.406     Document Type: Article

References (35)

1. Dunn PJ, Cole RA, Soeldner JS, Gleason RE. Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance. Ann Intern Med 1979;91:390-6.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulindependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
5. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, et al. Tests of glycemia in diabetes. Diabetes care 2004;27:1761-73.
6. Wu MS, Yu CC, Yang CW, Wu CH, Haung JY, Hong JJ, et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 1997;12:2105-10.
7. Morioka T, Emoto M, Tabata T, Shoji T, Tahara H, Kishimoto H, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001;24:909-13.
8. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 2005;16:3411-7.
9. Oomichi T, Emoto M, Tabata T, Morioka T, Tsujimoto Y, Tahara H, et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006;29:1496-500.
10. Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 1998;37:826-30.
11. Chujo K, Shima K, Tada H, Oohashi T, Minakuchi J, Kawashima S. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Invest 2006;53:223-8.
12. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007;18:896-903.
13. Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, Knovich MA, et al. Comparison of glycated albumin and hemoglobin A (1c) levels in diabetic subjects on hemodialysis. Kidney Int 2008;73:1062-8.
14. Morgan L, Marenah CB, Jeffcoate WJ, Morgan AG. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure. Diabet Med 1996;13:514-9.
15. Joy MS, Cefalu WT, Hogan SL, Nachman PH. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 2002;39:297-307.
16. Ansari A, Thomas S, Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis 2003;41:523-31.
17. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int 2006;70:1503-9.
18. Jones IR, Owens DR, Williams S, Ryder RE, Birtwell AJ, Jones MK, et al. Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care 1983;6:501-3.
19. Ziel FH and Davidson MB. The role of glucosylated serum albumin in monitoring glycemic control in stable insulin-requiring diabetic out-patients. J Clin Endocrinol Metab 1987;64:269-73.
20. Worner W, Pfleiderer S, Rietbrock N. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control. Int J Clin Pharmacol Ther Toxicol 1993;31:218-22.
21. Takahashi S, Uchino H, Shimizu T, Kanazawa A, Tamura Y, Sakai K, et al. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007;54: 139-44.
22. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979;76:4258-61.
23. Dolhofer R and Wieland OH. Improvement of the thiobarbituric acid assay for serum glycosylprotein determination. Clin Chim Acta 1981;112:197-204.
24. Ney KA, Colley KJ, Pizzo SV. The standardization of the thiobarbituric acid assay for nonenzymatic glucosylation of human serum albumin. Anal Biochem 1981;118:294-300.
25. Reed P, Bhatnagar D, Dhar H, Winocour PH. Precise measurement of glycated serum albumin by column affinity chromatography and immunoturbidimetry. Clin Chim Acta 1986;161:191-9.
26. Ikeda K, Sakamoto Y, Kawasaki Y, Miyake T, Tanaka K, Urata T, et al. Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA). Clin Chem 1998;44:256-63.
27. Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 2002;324:61-71.
28. Kouzuma T, Uemastu Y, Usami T, Imamura S. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta 2004;346:135-43.
29. Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, et al. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem 2007;40:1398-405.
30. Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods; approved guideline EP5-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2006.
31. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500.
32. Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline EP6-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2003.
33. Clinical and Laboratory Standards Institute. Interference testing in clinical chemistry; approved guideline EP7-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2005.
34. Clinical and Laboratory Standards Institute. How to define and determine reference intervals in the clinical laboratory; approved guideline C28-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2000.
35. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, et al., eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. St. Louis: Elsevier Saunders, 2006:837-902.